【FDA宣布礼来糖尿病药物Mounjaro和减肥药物Zepbound将在今年第二季度面临限量供应,5毫克至15毫克剂量供应量有限,2.5毫克剂量治疗药物则有货】 美国食品和药物管理局(FDA)近日在其官网上发布公告,表示由于需求增加,礼来公司的糖尿病药物Mounjaro和减肥药物Zepbound将在2023年第二季度面临限量供应,特别是5毫克至15毫克剂...
In anew commercialreleased Feb. 23, the Mounjaro maker calls out patients who are taking these medications without meeting the approval requirements from the FDA. The ad, titled "Big Night," was released right before the March 10 Academy Awards, and features shots of things you would see at ...
“There is a lot of lumpiness in channel stocking,” CEO Dave Ricks said on the call. “Downstream customers from Lilly, wholesalers and retailers, are making their own decisions about which of the 12 dosage forms [of Zepbound and Mounjaro] they want to stock and at what level.” Ricks...
Shares of Indianapolis-based Eli Lilly and Co. jumped more than 9% to $845.42 Thursday afternoon. The Standard & Poor’s 500 index rose more than 2%. The stock has already set several new all-time high prices this year, the latest happening last month when shares reached $966.10. ...
which have gained popularity for their ability to induce weight loss quickly. Zepbound's main ingredient istirzepatide, the same as Mounjaro, also made by Eli Lilly and FDA-approved to treat Type 2 diabetes. Both Zepbound and Mounjaro work by mimicking two different types of hormones that ...
"I think what we really don't control and don't attempt to but as a reality is that downstream customers from Lilly, wholesalers and retailers, are making their own decisions about which of the 12 different dosage forms they want to stock in at what level," Ricks said. ...
The medications have become so popular thatweight loss-focused companies like Noomand WW, in which Winfrey owns stock and sits on the board, havejumped into the obesity drugs market as well. MORE: First came Ozempic for weight loss, then came the shaming. ...